Biofil Chemicals & Pharmaceuticals informs about quarterly statement on investor complaints

06 Jan 2017 Evaluate

Biofil Chemicals & Pharmaceuticals has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Biofil Chem & Pharma Share Price

64.15 0.33 (0.52%)
29-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1478.35
Dr. Reddys Lab 6009.45
Cipla 1491.00
Zydus Lifesciences 1046.55
Lupin 1601.30
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.